Famotidine Injection, USP, 20 mg/2mL, 2 mL vial, Rx only, Single Dose Vial, For Intravenous Use Only After Dilution, Distributed by HF Acquisition Co, LLC, Mukilteo, WA 98275, NDC 63323-739-12

FDA recall notice · announced July 29, 2020 · Hf Acquisition Co

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

Famotidine Injection, USP, 20 mg/2mL, 2 mL vial, Rx only, Single Dose Vial, For Intravenous Use Only After Dilution, Distributed by HF Acquisition Co, LLC, Mukilteo, WA 98275, NDC 63323-739-12

Reason for recall

TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.

Notes

Distribution: The vials were distributed to one consignee located in CT.
Lot/code information: Lot #: 6122639, Exp. Date 08/2021
Quantity: N/A
Status: Terminated
Products in this recall event:
- Famotidine Injection, USP, 20 mg/2mL, 2 mL vial, Rx only, Single Dose Vial, For Intravenous Use Only After Dilution, Distributed by HF Acquisition Co, LLC, Mukilteo, WA 98275, NDC 63323-739-12 (D-1392-2020)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.